Navigation Links
Brin Wojcicki Foundation Announces $50-Million Challenge Grant to Michael J. Fox Foundation to Spur Progress Toward Parkinson's Cure
Date:5/31/2011

osity already has resulted in seminal contributions to the LRRK2 field by MJFF-funded researchers and an unprecedented level of collaboration among all players," said Todd Sherer, PhD, CEO of The Michael J. Fox Foundation. "We are excited to take on this Challenge — which we hope will inspire others to give generously — so that we can deploy similar strategies in other high-priority areas of PD research."

Michael J. Fox said: "Anne and Sergey's generosity to our Foundation, through their personal contributions and this Challenge, defies description. On behalf of the millions Parkinson's patients and their loved ones who stand to benefit, I'm more grateful than words can say."

Mr. Brin is co-founder of Google. Ms. Wojcicki is co-founder of 23andMe, a personal genetics company.

About The Michael J. Fox Foundation for Parkinson's Research

As the world's largest private funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers.  In addition to funding nearly $240 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world. For more information, visit: www.michaeljfox.org.


'/>"/>
SOURCE The Michael J. Fox Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. SyntheZyme Wins Second National Science Foundation Grant to Commercialize Promising Biopesticide
2. Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation
3. Bill & Melinda Gates Foundation Funds Bold Ideas Including Empty Virus Shells to Improve Polio Immunity, Dirt-Charged Cell Phones, and Fertilizer Pellets that Reduce Health Risks
4. Kanzius Cancer Research Foundation Earns $1 for Each New Facebook Fan
5. Fueling Interventional Radiology Growth: SIR Foundation Announces Navilyst Medical Pledge
6. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
7. Yuma Therapeutics Awarded a Research Grant by the Alzheimers Drug Discovery Foundation to Develop Novel Therapeutics for Alzheimers Disease
8. FXB Center Partners With The Merck Company Foundation to Reduce Mother-to-Child HIV Transmission Rates in Botswana
9. Medco Foundation Donates $100,000 to Red Cross for Japanese Earthquake and Pacific Tsunami Relief
10. Source Precision Medicine, Inc. d/b/a Source MDx Announces Foundational Patents Will Be Offered for Sale on April 29, 2011
11. Alzheimers Drug Discovery Foundation Supports ADispell Technology with a Grant to Advance Novel Drug Candidates for Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Wash. , Dec. 19, 2014  Advanced ... stage development company engaged primarily in the development ... and therapeutic applications, today announced that a Life ... has been awarded for which AMIC is the ... State University (WSU) for the proposal titled "Optimized ...
(Date:12/19/2014)... CHAPEL HILL, N.C. , Dec. 19, 2014 ... marketplace, innovative consumer research and marketing communication tools ... rich and globally competitive – consequently consumers, desires, ... In this environment, market research groups across ... research and marketing communication tools. However, the adoption ...
(Date:12/19/2014)... Dec. 18, 2014 Somewhere between dropping five ... was forgotten. But Audicus , a next-generation hearing ... this new year. Hearing loss is the ... population, though it is often unaddressed. Forty-eight million Americans ... a hearing aid, mainly due to price. Hearing aids ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 2Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 3Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Audicus Will Help People Resolve to Hear Better in 2015 2
... /PRNewswire-FirstCall/ --,Genta Incorporated announced the presentation of ... its marketed product, Ganite(R) (gallium,nitrate injection), plus ... relapsed or refractory non-Hodgkin's,lymphoma (NHL). The data ... American Society of Clinical Oncology (ASCO) in ...
... in 35% of HER2-Positive Metastatic Breast,Cancer ... /PRNewswire-FirstCall/ -- Kosan,Biosciences Incorporated presented data ... that alvespimycin, its second-generation Hsp90,inhibitor, demonstrated ... with trastuzumab (Herceptin(R)) in,patients with refractory ...
Cached Medicine Technology:Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 2Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 3Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 4Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 5Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 6
(Date:12/21/2014)... 2014 Parker & Sons, Inc. a ... plumbing and other similar home contractor services announces a ... to its expert contracting services. The company is considered ... been serving Arizona for well over 40 years. Parker ... best in quality customer service to the residents and ...
(Date:12/21/2014)... CannabisClassifieds.com celebrates marijuana’s new legal place at the ... its kind, the site has provided its faithful users with ... running. It uniquely combines the benefits of platforms like ... to the masses. Assuring the potent herb’s followers it’s ... public approval. , Shane Chattin, Owner of Cannabis ...
(Date:12/20/2014)... December 21, 2014 MissyDress, a distinguished ... all prom lovers. The business has drastically cut prices ... dresses to everyone until Jan. 30, 2015. Many of ... sweetheart dresses, V-neck dresses, lace dresses, and more. , ... not there every day. Whether A-line princess prom dresses ...
(Date:12/20/2014)... print component of Healthy Aging is distributed within today’s ... and an estimated readership of 420,000. The digital component ... and across a network of top news sites and ... campaign, click here . , The publication features ... The Social. Lainey Lui, Melissa Grelo, Traci Melchor, ...
(Date:12/20/2014)... 2014 As Risperdal lawsuits ( ... U.S. courts, Bernstein Liebhard LLP notes the publication ... treated with the medication may experience elevated levels ... and lactation. The study, which appears in International ... who began treatment with risperidone, an antipsychotic medication ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2Health News:MissyDress: The Prices of Prom Dresses Just Reduced 2Health News:The ladies of The Social urge Canadian women to put themselves first over the holiday season and into the new year in Mediaplanet’s “Women’s Health” campaign 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4
... Funding Suspension After Trial Failures, WASHINGTON, ... piece today ( http://www.baltimoresun.com/news/opinion/oped/bal -,op.aidsvaccine23mar23,0,3426636.story), AIDS Healthcare ... HIV vaccine research funding and the,re- allocation ... and treatment strategies., Co-authored by Dr. ...
... can shield children from harm , , SATURDAY, March 22 ... which concludes Saturday, the Soap and Detergent Association offers ... , Parents and caregivers should: , Install child-safety ... chemicals and other poisons. Never assume a cabinet is ...
... But it,s not too late to protect yourself and ... News) -- News from the diabetes front seems to ... the disease, fueled by obesity and sedentary lifestyles, have ... affecting about 7 percent of the population. That,s an ...
... N.C., March 21 A CI head once noted ... it, but the only,time you realize you need it ... today,s marketing space, most companies need competitive,intelligence to effectively ... key insights are lacking that people begin to realize ...
... are small, the trend is worrisome, study says ... small, but worrisome number of facelift patients became ... MRSA, a new study reports. , About one ... developed the so-called "superbug" methicillin-resistant Staphylococcus aureus ...
... and genetic testing, study shows , , FRIDAY, March ... discuss a family,s cancer history has a major impact ... women at moderate risk for breast cancer, according to ... black women are less likely than white women ...
Cached Medicine News:Health News:HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun 2Health News:HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun 3Health News:HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun 4Health News:Poison Prevention Tips to Protect the Most Vulnerable 2Health News:Diabetes' Toll Continues to Grow 2Health News:Diabetes' Toll Continues to Grow 3Health News:Diabetes' Toll Continues to Grow 4Health News:New Research Uncovers How to Build and Maintain an Effective Competitive Intelligence Group 2Health News:Some Facelift Patients Infected With MRSA 'Superbug' 2Health News:Some Facelift Patients Infected With MRSA 'Superbug' 3Health News:Family Discussion Plays Role in Breast Cancer Awareness 2
... Implant (KGTI) system offers the latest technology ... MPJ. The implant system is anatomically designed ... ,The KGTI is the most advanced reconstructive ... on the market today. The system consists ...
... Nerve Electrodes provide direct cranial nerve ... patented circumferential design provides sensitive contact ... stable real-time recordings. This unique approach ... the removal of acoustic neuromas, microvascular ...
... Ad-Techs Model CMU Cortical Mapping Unit ... of recording EEGs from exposed cortex during ... each electrode plate can be positioned independently ... clamp provides two alternative mounting locations and ...
An ambulatory recorder can help the patient be more comfortable and at ease as well as increasing an EEG laboratory's recording capacity....
Medicine Products: